This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Endometrial ablation

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Menorrhagia can be treated by removal of the endometrial layer of the uterus. This can be achieved by destruction of the basal layer, so preventing menstruation. Subsequent blastocyst implantation and hence pregnancy is less likely, but both uterine and ectopic pregnancies have still occurred - contraception is still indicated.

Endometrial ablation (1,2):

  • second-generation endometrial ablation should be considered as a treatment option for women with HMB and fibroids of 3 cm or more in diameter who meet the criteria specified in the manufacturers' instruction (2)
  • in women with HMB alone, with uterus no bigger than a 10-week pregnancy, endometrial ablation should be considered preferable to hysterectomy (1)
  • second-generation ablation techniques should be used where no structural or histological abnormality is present
    • impedance-controlled bipolar radiofrequency ablation
    • fluid-filled thermal balloon endometrial ablation
    • microwave endometrial ablation
    • free fluid thermal endometrial ablation

Advise women to avoid subsequent pregnancy and use effective contraception, if needed, after endometrial ablation.

Reference:

  1. NICE (January 2007). Heavy menstrual bleeding.
  2. NICE (March 2018). Heavy menstrual bleeding

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.